Stemming the spread of cancer

Angiogenesis.

Okayama University's Masaharu Seno and colleagues have demonstrated in vitro the development of cancer stem cells (CSCs) from a type of normal stem cell exposed to their hypothetical microenvironment of a tumor.

Cancer (CSCs) have been proposed as an explanation for the spread of cancer. These cells are tumorigenic and have the capacity of both self-renewal and differentiation into a range of various cell types. In this concept, provide heterogeneous aspects derived from CSCs as well as normal stem cells provide tissue specific phenotype in response to their microenvironment.

Spheroid GFP.

Researchers have now demonstrated in vitro the development of CSCs from a type of normal stem cell exposed to their hypothetical microenvironment of a tumor. The results are the work of a group of scientists led by Masaharu Seno, a professor of Okayama University, with his collaborators in China and the US.

The researchers cultured mouse induced pluripotent stem (miPS) cells in a conditioned medium obtained from a number of mouse cancer cell lines. Finally, a population of stem cells was kept undifferentiated and proliferating while other stem cells differentiated into specialized cells, which were incapable of proliferation any more.

Immunostain.

Since the survived miPS cells treated with the conditioned medium were found malignantly tumorigenic in vivo, they concluded that the cells could be defined as CSCs . "The model of CSCs and the procedure of their establishment will help study the and the secreted factors in the which convert miPS cells to CSCs," explain the authors. The work should help breakthrough towards the development of new therapies to combat cancer.

More information: Ling Chen et al., A model of cancer stem cells derived from mouse induced pluripotent stem cells. PLoS One 7, e33544 (2012). DOI: 10.1371/journal.pone.0033544

add to favorites email to friend print save as pdf

Related Stories

Researchers attack stem cells that cause colon cancer

Apr 28, 2010

Many of the colon cancer cells that form tumors can be killed by genetically short-circuiting the cells' ability to absorb a key nutrient, a new study has found. While the findings are encouraging, the test tube study using ...

Discovery halts breast cancer stem cells

Nov 23, 2010

Breast cancer stem cells (CSCs), the aggressive cells thought to be resistant to current anti-cancer therapies and which promote metastasis, are stimulated by estrogen via a pathway that mirrors normal stem cell development. ...

Recommended for you

Blood biomarker may detect lung cancer

10 hours ago

A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract ...

ACG: Recent increase in incidence of young-onset CRC

Oct 20, 2014

(HealthDay)—The incidence of young-onset colorectal cancer (CRC) is increasing, and the disease is more aggressive pathologically. These findings are being presented at the annual meeting of the American ...

User comments